A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease

  • Clive Hamlin
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Gianfranco Puoti
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Sally Berri
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Elliott Sting
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Carrie Harris
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Mark Cohen
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Charles Spear
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Alberto Bizzi
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Sara M. Debanne
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.
  • Douglas Y. Rowland
    From the Departments of Pathology (National Prion Disease Pathology Surveillance Center) (C.H., G.P., S.B., E.S., C.H., M.C., C.S.) and Epidemiology and Biostatistics (S.D., D.Y.R.), Case Western Reserve University, Cleveland, OH; and Istituto Neurologico Carlo Besta (A.B.), Milan, Italy.

収録刊行物

  • Neurology

    Neurology 79 (6), 547-552, 2012-08-07

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ